125 186

Cited 0 times in

A Case of Improved Refractory Uveitis in Behçet’s Disease after Infliximab Therapy

Other Title
Infliximab 치료 후 호전된 난치성 포도막염을 동반한 베체트병 1예
최, 정우; 최, 용준; 예, 영민; 김, 상하; 남, 동호; 박, 해심; 이, 마빈; 유, 호민; 서, 창희
The Journal of the Korean Rheumatism Association, 12(4):320-323, 2005
Journal Title
The Journal of the Korean Rheumatism Association; 대한류마티스학회지
Behçet's disease is a multisystemic, chronic relapsing inflammatory disease characterized by vasculitides, mucocutaneous lesions, thrombophlebitis, arthritis. Among them, the ocular involvement is usual (50∼70%) and the most serious morbidity is blindness (20∼25% of those of affected). Immunosuppressive treatment is currently the main therapy in chronic relapsing uveitis, but many patients experience recurrent sight-threatening uveitis. T lymphocytes play an important role in the pathogenesis of uveitis by releasing cytokines such as tumor necrosis factor (TNF) α. There are some reports that the anti-TNFα treatment is effective in refractory Behçet's uveitis, but it has not been reported in Korea. We report a case of refractory uveitis in Behçet's disease which is improved after anti-TNFα therapy.
Behçet's diseaseUveitisTNFαAnti-TNFα treatment
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Files in This Item:
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.